<p>[<sup>3</sup>H]-B[a]P recovered in blood 24 h after a single i.p. injection of [<sup>3</sup>H]-B[a]P (2 µg/kg) in mice immunised with B[a]P-peptide or B[a]P-TT conjugates, with (open bars) or without (closed bars) tetanus toxoid (TT) pre-vaccination. Results are expressed as mean ± S.E.M of 5 mice per group. **p<0.01, ***p<0.001 significant difference from controls (Two Way ANOVA followed by Bonferoni). Control groups are No pre-vaccination (closed bars) or animals without B[a]P vaccination (No vaccination).</p
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Challenge of mice vaccinated with BCGpan-Gag or BCGpan-Control vaccine with VV-Gag or VV-NYCBH. G...
<p>C57BL/6 mice (○) or C57BL/6 mice depleted of CD4 and CD8 T cells (◊) were (A) vaccinated with 10<...
<p>[<sup>3</sup>H]-B[a]P (in Bq/g tissue weight or Bq) recovered in blood (A), tissues (B–liver, C–b...
<p>(A) Endpoint titers (serum dilution reaching 5 times the background) for TT specific IgG antibodi...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p><b>A.</b> For therapeutic vaccination, mice (n = 5 per group) were inoculated with ID8-G7 tumor c...
<p>Fourteen days after the second dose, mice were i.n. challenged with 40 µl of X-31, and weight cha...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>At day 0, mice were i.m. injected with LPS, CFA or with one of the vaccines (TIV<sup>+</sup>, TIV...
<p>Bacterial burden in tissues was significantly lower in animal immunized with Peptide B especially...
<p><b>(a)</b> Peripheral blood TB10 tetramer<sup>+</sup> responses 8w post-prime or 8w post-boost wi...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Challenge of mice vaccinated with BCGpan-Gag or BCGpan-Control vaccine with VV-Gag or VV-NYCBH. G...
<p>C57BL/6 mice (○) or C57BL/6 mice depleted of CD4 and CD8 T cells (◊) were (A) vaccinated with 10<...
<p>[<sup>3</sup>H]-B[a]P (in Bq/g tissue weight or Bq) recovered in blood (A), tissues (B–liver, C–b...
<p>(A) Endpoint titers (serum dilution reaching 5 times the background) for TT specific IgG antibodi...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p><b>A.</b> For therapeutic vaccination, mice (n = 5 per group) were inoculated with ID8-G7 tumor c...
<p>Fourteen days after the second dose, mice were i.n. challenged with 40 µl of X-31, and weight cha...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>At day 0, mice were i.m. injected with LPS, CFA or with one of the vaccines (TIV<sup>+</sup>, TIV...
<p>Bacterial burden in tissues was significantly lower in animal immunized with Peptide B especially...
<p><b>(a)</b> Peripheral blood TB10 tetramer<sup>+</sup> responses 8w post-prime or 8w post-boost wi...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
Groups of 10 Balb/c mice were immunized with Flg-HA2-2-4M2e, Flg-HA2-1-4M2e, or Flg-4M2e fusion prot...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
<p>Challenge of mice vaccinated with BCGpan-Gag or BCGpan-Control vaccine with VV-Gag or VV-NYCBH. G...
<p>C57BL/6 mice (○) or C57BL/6 mice depleted of CD4 and CD8 T cells (◊) were (A) vaccinated with 10<...